Circulating human hepatic lipase mRNA in patients with hepatocellular carcinoma and healthy controls

European Journal of Surgery

Volumn 165, Issue 6, 1999, Pages 539-542

  Leonhardt, Urs ^a   Ritzel, Uwe ^a   Ottleben, Martin ^a   Ramadori, Giuliano ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Hepatic lipase; Hepatocellular carcinoma; Human hepatic lipase messenger RNA; RT PCR

Indexed keywords

LIVER TRIACYLGLYCEROL LIPASE; MESSENGER RNA;

ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATOMA CELL; HUMAN; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIPASE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0032802103     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: 10.1080/110241599750006424     Document Type: Article

References (15)

1. Ameis D, Stahnke G, Kobayashi J, et al. Isolation and characterization of the human hepatic lipase gene. J Biol Chem 1990; 265: 6552-6555.
2. Barbu V, Bonnand AM, Hillaire S, et al. Circulating albumin messenger RNA in hepatocellular carcinoma: results of a multicenter prospective study. Hepatology 1997; 26: 1171-1175.
3. Busch SJ, Krstenansky JL, Owen TJ, Jackson RL. Human hepatoma (HepG2) cells secrete a single 65 K dalton triglyceride lipase immunologically identical to postheparin plasma lipase. Life Sci 1989; 45: 615-622.
4. Carr BI. An assay for micrometastatic hepatocellular carcinoma. Gastroenterology 1994; 106: 264-267.
5. Chelly J, Concordet JP, Kaplan JC, Khan A. Illegitimate transcription of any gene in any cell type. Proc Natl Acad Sci USA 1986; 86: 2617-2621.
6. Chou HC, Sheu JC, Huang GT, Wang JT, Chen DS. Albumin messenger RNA is not specific for circulating hepatoma cells. Gastroenterology 1994; 107: 630-631.
7. Datta S, Luo CC, Li WH, et al. Human hepatic lipase: Cloned cDNA sequence, restricting fragment length, polymorphismus, chromosomal localization, and evolutionary relationships with lipoprotein lipase and pancreatic lipase. J Biol Chem 1988; 263: 1107-1110.
8. Hillaire S, Barbu V, Boucher E, Moukhtar M, Poupon R. Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma. Gastroenterology 1994; 106: 239-242.
9. Ikeda K, Saitoh S, Tsubota A, et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993; 71: 19-25.
10. Kar S, Carr BI. Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma. Hepatology 1995; 21: 403-407.
11. Kinnunen PKJ, Vitanen JA, Vaino P. Lipoprotein lipase and hepatic endothelial lipase: their role in plasma lipoprotein metabolism. Atherosclerosis Rev 1983; 11: 65-105.
12. Leonhardt U, Ritzel U, Ottleben M, Vignoli A, Ramadori G. Detection of circulating albumin-mRNA by RT-PCR does not indicate metastasizing hepatocellular carcinoma. Langenbecks Arch Chir 1997; 382: 83-86.
13. McLeod JF, Cooke NE. The vitamin D-binding protein, alpha-fetoprotein, albumin multigene family: detection of transcripts in multiple tissues. J Biol Chem 1989; 264: 21760-21769.
14. McPeake JR, O'Grady JG, Zaman S, et al. Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol 1993; 18: 226-234.
15. Yokoyama I, Todo S, Iwatsuki S, Starzl TE. Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 1990; 37: 188-193.